In case of increased production of mutated or misfolded proteins in the ER, as it may occur in neurodegenerative diseases, blockade of translation by eIF2α phosphorylation appears appropriate; however, such response would not be advantageous for proliferating leukemia cells. The gene discussed is EIF2A; the disease is leukemia.